Welcome to the Working Group on New TB Drugs Blog
Posted in TB News, TB Pediatrics, TB Prevention and Control Strategies, TB Treatment, Uncategorized
TB R&D Weekly Update: Latent TB Treatment in HIV and Children
In the July 7 issue of the New England Journal, two articles and an editorial on latent TB and TB prevention are published. One study discusses positive results on a treatment for latent TB in HIV-infected persons. The other study discusses negative findings that isoniazid is not effective in latent treatment of tuberculosis in children regardless of HIV status. A link to MedPage Today is included that provides a good overview of these studies and the editorial. Additional TB R&D News Links also are included.
Posted in Action, Announcements, Events, TB News, TB Prevention and Control Strategies, TB Treatment
Call to Action–Save a million lives by 2015
On June 6, 2011, the Stop TB Partnership launched the initiative Time to Act–Save a Million Lives by 2015 at the UN Headquarters at a reception hosted by Ray Chambers, the UN Secretary-General’s Special Envoy for Malaria and UN MDG Advocate. If you would like to respond to this call to action, visit www.action.org.
Posted in Announcements, Faces of TB, TB Diagnostics, TB News, Voices from the Fight to Stop Tuberculosis
Announcement: World-Renowned Pulmonologist Michael Iseman Joins Oxford Immunotec
Dr. Michael D. Iseman, a world renowned pulmonologist and leading expert on tuberculosis has joined Oxford Immunotec as the Senior Scientific Advisor. In May 2010, the WGND had the honor of interviewing Dr. Iseman in our “Voices from the Fight to Stop TB” series. We congratulate Dr. Iseman on is new position!
Announcement: Promising TB vaccine candidate progresses to Phase I clinical trials
The MTBVAC01 vaccine candidate, developed to protect people against tuberculosis, will start Phase I clinical trials early in 2012. This was announced by the Spanish biopharmaceutical company Biofabri. The candidate was developed by the University of Zaragoza, Spain and is part of the international portfolio of TuBerculosis Vaccine Initiative (TBVI). Tuberculosis causes almost two million deaths per year.
Announcement: Dr. Peter Andersen Awarded Prestigious Scientific Prize
Dr. Peter Andersen, the Vice President of Vaccine Research and Development at Statens Serum Institut (SSI) and TBVI partner, has been awarded the prestigious Novo Nordisk prize for his work in TB vaccine development. The WGND interviewed Dr. Andersen for our TB R&D Weekly Update on March 8. Congratulations to Dr. Andersen! For full story, [...]
Posted in Announcements, market access, TB News, TB Prevention and Control Strategies, TB Treatment, Video
Private TB Drug Market is Larger than Expected
The first detailed study of the private tuberculosis (TB) drug market, published on May 4th, in the PLoS ONE journal, finds that the market is surprisingly large, and has irregular practices that could be driving treatment failures and contributing to the emergence of multidrug-resistant TB (MDR-TB).
Announcement: Call for Applications for Membership of the Global GLC
The Stop TB Partnership and the World Health Organization are announcing a call for applications for members to serve on the Global GLC Committee. Deadline for submission of applications is 16 May 2011.
Stop TB News – April 2011
This is the April 2011 edition of Stop TB News, which is distributed by email by the Stop TB Partnership.
CNN News Coverage and FIND Presentation on Rapid TB test, Xpert MTB/RIF
CNN featured TB diagnostic Xpert MTB/RIF in its Inside Africa program and looked at the implementation of Xpert MTB/RIF in Uganda. In addition, the CORE Group hosted an online presentation on Xpert MTB/RIF from Elizabeth Talbot, Associate Professor of Infectious Diseases and International Health at Dartmouth Hitchcock Medical Center, and Medical Scientist, FIND: Foundation for Innovative New Diagnostics. Results of a survey of their TB Working Group listserv also is included.
Stop TB Partnership’s Coordinating Board Meets in DC
Today was the opening of the 2-day Stop TB Partnership’s Coordinating Board (CB) meeting in Washington, D.C. which included welcoming remarks by Dr. Rajiv Shah (Administrator, USAID), Ms. Lois Quam (Executive Director, GHI), and Dr. Howard Koh (Assistant Secretary, U.S. Depart. of HHS).
-
You are currently browsing the archives for the TB News category.
-
Toppix TB News- Editorial: Lives at risk if the U.S. shortchanges Global Fund 4 Feb 2012
- Multidrug-Resistant Tuberculosis - Update 3 Feb 2012
- Multidrug-Resistant Tuberculosis - Update 3 Feb 2012
- WHO says TB in Russia displays highest known drug resistance 3 Feb 2012
- Media outlets examine Global Fund's future as it enters second decade 3 Feb 2012
